Prestige Consumer Healthcare (PBH) Accounts Payables (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Accounts Payables of $42.9 million in Q4 2025, up 2.44% quarter-over-quarter from $41.9 million in Q3 2025, and up 120.17% on a YoY basis from $19.5 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Accounts Payables (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Accounts Payables history runs 15 years deep, the most recent figure standing at $42.9 million for Q4 2025.
- In Q4 2025, Accounts Payables rose 120.17% year-over-year to $42.9 million; the TTM figure through Dec 2025 stood at $42.9 million (up 120.17% YoY), while the FY2025 annual figure was $18.9 million, down 51.45% from the prior year.
- Accounts Payables was $42.9 million for Q4 2025 at Prestige Consumer Healthcare, up from $41.9 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $64.3 million in Q4 2022 to a low of $18.9 million in Q1 2025.
- Historically, Accounts Payables has averaged $42.4 million across 5 years, with a median of $41.0 million in 2021.
- Biggest YoY gain for Accounts Payables was 120.17% in 2025; the steepest drop was 51.45% in 2025.
- A 5-year view of Accounts Payables shows it stood at $40.1 million in 2021, then surged by 60.22% to $64.3 million in 2022, then plunged by 38.78% to $39.3 million in 2023, then plunged by 50.42% to $19.5 million in 2024, then soared by 120.17% to $42.9 million in 2025.
- The last three Accounts Payables figures came in at $42.9 million (Q4 2025), $41.9 million (Q3 2025), and $22.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 42.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42.95 Mn |
| Sep 30, 2025 | 41.92 Mn |
| Jun 30, 2025 | 22.21 Mn |
| Mar 31, 2025 | 18.93 Mn |
| Dec 31, 2024 | 19.51 Mn |
| Sep 30, 2024 | 31.17 Mn |
| Jun 30, 2024 | 39.56 Mn |
| Mar 31, 2024 | 38.98 Mn |
| Dec 31, 2023 | 39.34 Mn |
| Sep 30, 2023 | 44.38 Mn |
| Jun 30, 2023 | 57.86 Mn |
| Mar 31, 2023 | 62.74 Mn |
| Dec 31, 2022 | 64.25 Mn |
| Sep 30, 2022 | 56.20 Mn |
| Jun 30, 2022 | 58.11 Mn |
| Mar 31, 2022 | 55.76 Mn |
| Dec 31, 2021 | 40.10 Mn |
| Sep 30, 2021 | 38.05 Mn |
| Jun 30, 2021 | 30.96 Mn |
| Mar 31, 2021 | 45.98 Mn |